How many companies in cities across Burlington County received FDA citations in 2024?

How many companies in cities across Burlington County received FDA citations in 2024?
Suzanne Roosen Acting Director of the Office of Food Policy and Response (OFPR) — Official Website
0Comments

There were two companies in a city associated with Burlington County that received FDA citations as a result of two inspections conducted in the county throughout 2024, according to reports from the U.S. Food and Drug Administration (FDA).

This is a 100% increase over the number of companies cited in the previous year.

The citations in the county include:

  • HCT/Ps from ineligible donors which were made available for limited use were not prominently labeled with a statement warning of the reactive test results.
  • Donor specimens used for testing of communicable disease agents were not collected at the appropriate time.
  • Donors were not tested for evidence of infection with relevant communicable disease agents.

Both companies cited should take voluntary actions to correct their managing operations.

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.

Companies Located Within Burlington County Cities and the Citations They Received in 2024
Company Name Area of Business Inspection Date Issue Cited
Elan A. Cohen, Ph. D. Drugs 01/22/2024 Case history records- inadequate or inadequate
Regional Women’s Health Group, LLC Biologics 04/29/2024 Labeled re: biohazard, risks, test results
Regional Women’s Health Group, LLC Biologics 04/29/2024 Specimen collections not timely
Regional Women’s Health Group, LLC Biologics 04/29/2024 Infection with communicable disease agents


Related

Andy Kim U.S. House of Representatives from New Jersey's 3rd district

Senator Andy Kim addresses infrastructure projects and government accountability in March 2026 posts

Senator Andy Kim posted several updates on March 14, 2026 regarding New Jersey infrastructure improvements, calls for investigations into alleged political corruption during Trump’s administration, and support for local firefighters.

Lindsay S. See, Commissioner of Federal Energy Regulatory Commission (FERC)

Week ending Mar. 7: Lowest premium gas in Burlington County reaches $3.10

The cheapest per-gallon price for premium gas in Burlington County during the week ending Mar. 7 was $3.10 per gallon.

Andy Kim U.S. House of Representatives from New Jersey's 3rd district

Senator Andy Kim criticizes Trump administration over civilian protection center

Senator Andy Kim used social media on March 13-14, 2026 to address issues ranging from civilian protection during military operations to recognizing youth leaders from New Jersey.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Burlington Review.